CAS 136572-09-3
:Irinotecan hydrochloride trihydrate
Description:
Irinotecan hydrochloride trihydrate is a chemotherapeutic agent primarily used in the treatment of colorectal cancer. It is a water-soluble salt derived from the natural alkaloid camptothecin and functions as a topoisomerase I inhibitor, disrupting DNA replication and transcription in cancer cells. The substance appears as a white to off-white crystalline powder and is hygroscopic, meaning it can absorb moisture from the environment. Its molecular formula includes a hydrochloride component and three water molecules, contributing to its stability and solubility in aqueous solutions. Irinotecan is administered intravenously and is often used in combination with other chemotherapeutic agents to enhance efficacy. Common side effects include diarrhea, nausea, and myelosuppression, necessitating careful monitoring during treatment. The compound's pharmacokinetics involve metabolism primarily by the liver, with active metabolites contributing to its therapeutic effects and toxicity. Overall, irinotecan hydrochloride trihydrate plays a significant role in oncology, particularly in managing advanced-stage cancers.
Formula:C33H38N4O6·ClH·3H2O
InChI:InChI=1S/C33H38N4O6.ClH.3H2O/c1-3-22-23-16-21(43-32(40)36-14-10-20(11-15-36)35-12-6-5-7-13-35)8-9-27(23)34-29-24(22)18-37-28(29)17-26-25(30(37)38)19-42-31(39)33(26,41)4-2;;;;/h8-9,16-17,20,41H,3-7,10-15,18-19H2,1-2H3;1H;3*1H2/t33-;;;;/m0..../s1
InChI key:InChIKey=KLEAIHJJLUAXIQ-JDRGBKBRSA-N
SMILES:C(C)C1=C2C(C=3N(C2)C(=O)C4=C(C3)[C@](CC)(O)C(=O)OC4)=NC=5C1=CC(OC(=O)N6CCC(CC6)N7CCCCC7)=CC5.Cl.O
Synonyms:- (+)-7-Ethyl-10-[4-(1-piperidino)-1-piperidino]-carbonyloxycamptothecin, monohydrochloride, trihydrate
- (+)-7-Ethyl-10-hydroxycamptothecine 10-(1,4'-bipiperidine)-1'-carboxylate, monohydrochloride, trihydrate
- (1,4'-Bipiperidine)-1'-Carboxylicacid,4,11-Diethyl-3,4,12,14-Tetrahydro-4-Hyd Monohydrochloride, Trihydrate
- (1,4'-Bipiperidine)-1'-carboxylic acid, 4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano(3',4':6,7)indolizino(1,2-b)quinolin-9-yl ester, monohydrochloride, trihydrate, (S)-
- (19S)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.0^{2,11}.0^{4,9}.0^{15,20}]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaen-7-yl [1,4'-bipiperidine]-1'-carboxylate trihydrate hydrochloride
- (S)-4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl [1,4'-bipiperidine]-1'-carboxylate hydrochloride trihydrate
- (S)-[1,4'-Bipiperidine]-1'-Carboxylic Acid 4,11-Diethyl-3,4,12,14-Tetrahydro-4-Hydroxy-3,14-Dioxo-1H-Pyrano
- (S)-[1,4'-Bipiperidine]-1'-carboxylic acid 4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl ester hydrochloride trihydrate
- 1H-Pyrano[3′,4′:6,7]indolizino[1,2-b]quinoline, [1,4′-bipiperidine]-1′-carboxylic acid deriv.
- Camptosar
- Irinotecan HCl trihydrate
- Irinotecan Monohydrochloride Trihydrate
- Irinotecan hydrochloride hydrate
- Irinotecanhydrochloridetrihydrate(Cpt-11)
- Onivyde
- Onivyde pegylated liposomal
- Roxy-3,14-Dioxo-1H-Pyrano(3',4',6,7)Indolizino(1,2-B)Quinolin-9-Ylester,Mono
- Trihydrate,(S)-Hydrochlorid Trihydrate
- [1,4'-Bipiperidine]-1'-Carboxylic Acid (S)-4,11-Diethyl-3,4,12,14-Tetrahydro-4-Hydroxy-3,14-Dioxo-1H-Pyrano
- [1,4'-Bipiperidine]-1'-carboxylic acid, (4S)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl ester, hydrochloride, hydrate (1:1:3)
- [1,4′-Bipiperidine]-1′-carboxylic acid, (4S)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinolin-9-yl ester, hydrochloride, hydrate (1:1:3)
- [1,4′-Bipiperidine]-1′-carboxylic acid, (4S)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinolin-9-yl ester, monohydrochloride, trihydrate
- [1,4′-Bipiperidine]-1′-carboxylic acid, 4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinolin-9-yl ester, monohydrochloride, trihydrate, (S)-
- [3',4',6,7]Indolizino[1,2-B]Quinolin-9-Yl Ester, Hcl Trihydrate
- See more synonyms
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Irinotecan Hydrochloride Trihydrate
CAS:Formula:C33H38N4O6·HCl·3H2OPurity:>98.0%(T)(HPLC)Color and Shape:White to Orange to Green powder to crystalMolecular weight:677.20Irinotecan hydrochloride trihydrate, 99%
CAS:<p>Topoisomerase I inhibitor</p>Formula:C33H45ClN4O9Purity:99%Molecular weight:677.19IRINOTECAN HYDROCHLORIDE TRIHYDRATE CRS
CAS:<p>IRINOTECAN HYDROCHLORIDE TRIHYDRATE CRS</p>Formula:C33H38N4O6Color and Shape:Powder. Yellow. Light Yellow.Molecular weight:586.678IRINOTECAN FOR SYSTEM SUITABILITY 2 CRS
CAS:<p>IRINOTECAN FOR SYSTEM SUITABILITY 2 CRS</p>Formula:C33H38N4O6Color and Shape:Powder. Yellow. Light Yellow.Molecular weight:586.678IRINOTECAN FOR PEAK IDENTIFICATION CRS
CAS:<p>IRINOTECAN FOR PEAK IDENTIFICATION CRS</p>Formula:C33H38N4O6Color and Shape:Powder. Yellow. Light Yellow.Molecular weight:586.678Irinotecan Hydrochloride
CAS:Other alkaloids,natural or reproduced by synthesis, and their salts, ethers,esters&other derivatives, nesoiFormula:C33H38N4O6·HCl·3H2OColor and Shape:Pale Yellow Yellow PowderMolecular weight:677.18Irinotecan hydrochloride trihydrate
CAS:Formula:C33H45ClN4O9Purity:98%Color and Shape:SolidMolecular weight:677.1848Irinotecan hydrochloride trihydrate
CAS:<p>Irinotecan hydrochloride trihydrate (CPT-11 HCl Trihydrate) keeps DNA from unwinding by inhibiting topoisomerase 1.</p>Formula:C33H45ClN4O9Purity:98.22% - >99.99%Color and Shape:Pale Yellow To Yellow Crystalline PowderMolecular weight:677.18Irinotecan hydrochloride trihydrate
CAS:Irinotecan hydrochloride trihydratePurity:≥98%Molecular weight:677.18g/molIrinotecan hydrochloride trihydrate
CAS:Formula:C33H38N4O6·HCl·3(H2O)Purity:≥ 99.0% (anhydrous)Color and Shape:Off-white to yellow crystalline powderMolecular weight:623.14 (anhydrous)Irinotecan Hydrochloride Trihydrate
CAS:Irinotecan Hydrochloride TrihydratePurity:98%Molecular weight:677.18g/molIrinotecan Hydrochloride Trihydrate
CAS:Controlled ProductFormula:C33H38N4O6·ClHH2OColor and Shape:NeatMolecular weight:677.18Irinotecan Hydrochloride Trihydrate
CAS:Controlled Product<p>Applications Irinotecan Hydrochloride Trihydrate is a DNA topoisomerase inhibitor.<br>References Kunimoto, T., et al.: Cancer Res., 47, 5944 (1987), Shimada, Y., et al.: J. Clin. Oncol., 11, 909 (1993)<br></p>Formula:C33H38N4O6·ClH·3H2OColor and Shape:Light YellowMolecular weight:677.18Irinotecan Hydrochloride Trihydrate
CAS:Formula:C33H38N4O6HCl(H2O)Molecular weight:586.69 : 36.46 : 3(18.0)Irinotecan hydrochloride trihydrate - Bio-X ™
CAS:<p>Irinotecan hydrochloride trihydrate is a topoisomerase I inhibitor that is used as chemotherapy drug for colorectal cancer. By inhibiting topoisomerase I, Irinotecan hydrochloride trihydrate prevents the replication of DNA in cells, and stops the cancer cells from growing and dividing. When used for chemotherapy, Irinotecan hydrochloride trihydrate is usually part of combination therapy with other chemotherapy drugs, such as 5-fluorouracil (5-FU) and leucovorin for other cancers.</p>Formula:C33H38N4O6•HCl•(H2O)3Purity:Min. 95%Color and Shape:PowderMolecular weight:677.18 g/molIrinotecan hydrochloride trihydrate
CAS:<p>Inhibitor of DNA topoisomerase I</p>Formula:C33H38N4O6•HCl•(H2O)3Purity:Min. 97 Area-%Color and Shape:Yellow PowderMolecular weight:677.18 g/mol(R)-Irinotecan Hydrochloride-d10 Trihydrate
CAS:Controlled ProductFormula:C33H35D10ClN4O9Color and Shape:NeatMolecular weight:687.25














